WallStSmart
PLSM

Pulsenmore Ltd. Ordinary Shares

NASDAQ: PLSM · HEALTHCARE · MEDICAL DEVICES

$3.63
-4.82% today

Updated 2026-06-05

Market cap
$25.91M
P/E ratio
P/S ratio
1.86x
EPS (TTM)
$-0.85
Dividend yield
52W range
$3 – $2,226
Volume
0.0M

Pulsenmore Ltd. Ordinary Shares (PLSM) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2019202020212022202320242025
Operating cash flow$-3.83M$-9.47M$-26.01M$-24.51M$-42.45M$-33.71M$-32.88M
Capital expenditures$185676.00$389234.00$774423.00$4.41M$3.89M$507847.00$135000.00
Depreciation
Stock-based comp$2.04M$4.73M$3.28M$1.39M$667000.00
Free cash flow$-4.01M$-9.85M$-26.79M$-28.92M$-46.34M$-34.22M$-33.01M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash

Frequently asked questions

How profitable is PLSM?

In its most recent fiscal year, PLSM ran a gross margin of 84.15%, an operating margin of -30.39%, and a net margin of -39.61%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does PLSM generate?

PLSM produced $-33.01M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is PLSM's balance sheet healthy?

PLSM holds $21.60M in cash and equivalents against — in long-term debt, on $83.09M of shareholder equity. That debt is best read against the cash flow the business throws off each year.